China's National Health Security Administration said on Sunday that Pfizer's Paxlovid oral medication, which is used to treat Covid-19, could not be included in the "register of drugs in the basic medical insurance", because the company's quotation was too high, media reports here said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8j4VEnr
via IFTTT
0 comments:
Post a Comment